Both in Biotechnology
TScan Therapeutics vs Jasper Therapeutics
Over the past year TCRX returned −81.8% and JSPR returned −74.9%; their daily moves had a correlation of 0.11.
TCRX −81.8% JSPR −74.9%Growth of $1, one year, split-adjusted
| Metric | TCRX | JSPR |
|---|---|---|
| Price | $0.3175 | $0.6254 |
| Market cap | $21.5M | $20.8M |
| Today | −6.62% | −0.10% |
| 1 month | −57.9% | −10.6% |
| 6 months | −66.2% | −30.5% |
| Year to date | −68.3% | −65.8% |
| 1 year | −82.8% | −74.7% |
| Revenue growth (YoY) | −65.8% | — |
| Gross margin | 100.0% | — |
| Net margin | −2888.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.0× | — |
| Net cash | $67.4M | $7.3M |
| Dividend yield | — | — |
| Volatility (60d) | 138.5% | 100.6% |
| Short % of float | 4.5% | 25.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).